Last reviewed · How we verify
Iothion (diiodohydroxypropane)
Iothion (generic name: diiodohydroxypropane) is a diiodohydroxypropane drug. It is currently in unknown development.
Iothion works by interacting with specific biological molecules to produce a therapeutic effect.
Iothion, also known as diiodohydroxypropane, is a small molecule drug of unknown target and class. Its commercial status and approved indications are currently unknown. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand the properties and potential uses of Iothion.
At a glance
| Generic name | diiodohydroxypropane |
|---|---|
| Drug class | diiodohydroxypropane |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like locks, and Iothion is a key that fits into those locks. When it binds to the right lock, it can help turn off or turn on certain cellular processes to treat a disease or condition. This is a simplified way of thinking about how small molecules like Iothion work to produce their effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iothion CI brief — competitive landscape report
- Iothion updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Iothion
What is Iothion?
How does Iothion work?
What is the generic name of Iothion?
What drug class is Iothion in?
What development phase is Iothion in?
Related
- Drug class: All diiodohydroxypropane drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing